-
Oxford joins consortium to advance quantum drug discovery
pharmatimes
January 11, 2022
The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order to reduce the development time required for drug production worldwide.
-
New blood test can identify presence of cancer
pharmatimes
January 05, 2022
The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented.
-
Oxford and AstraZeneca aim to produce Omicron-targeted version of vaccine
pharmatimes
December 22, 2021
Calls for booster vaccinations in order to combat the rising cases brought about by winter and the recent Omicron variant have intensified, in the midst of record case rates.
-
GSK and the University of Oxford launch new Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease
WorldPharmaNews
December 06, 2021
GlaxoSmithKline plc and the University of Oxford announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine. The new Institute, which will be based at the University of Oxford, aims to...
-
Orbit Discovery raises $7.6m to boost peptide drug discovery services
pharmatimes
July 22, 2021
Oxford, UK-based Orbit Discoveries has raised $7.6m in funding to boost its peptide drug discovery services and accelerate the growth of its business.
-
Oxford researchers launch HIV vaccine trial
pharmatimes
July 07, 2021
The University of Oxford has launched a Phase I trial of a novel mosaic vaccine targeting a ‘broad range’ of HIV variants.
-
Over a quarter of UK adults have received both COVID-19 vaccine doses
pharmatimes
April 28, 2021
The Department of Health and Social Care (DHSC) has announced that over a quarter of adults in the UK have now received both doses of a COVID-19 vaccine in the latest vaccination milestone.
-
Oxford AstraZeneca jabs effective against severe COVID new trial in US confirms
expresspharma
March 24, 2021
Oxford University said that the absolute efficacy of the jabs is higher in the new study than observed in the Oxford-led studies.
-
Denmark suspends AZ/Oxford Covid-19 vaccination amid blood clot concerns
pharmaceutical-technology
March 12, 2021
The Danish National Board of Health has temporarily paused the roll-out of the AstraZeneca/Oxford Covid-19 vaccine.
-
Italy blocks export of 250,700 AstraZeneca/Oxford Covid-19 vaccines to Australia
pharmaceutical-technology
March 08, 2021
The Italian Government has refused to authorise the export of 250,700 doses of AstraZeneca/University of Oxford’s Covid-19 vaccine to Australia.